These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Bone marrow transplantation with ciclosporin. Gratwohl A; Speck B Prog Allergy; 1986; 38():404-31. PubMed ID: 3523495 [No Abstract] [Full Text] [Related]
7. Neurologic complications after allogeneic bone marrow transplantation. Gallardo D; Ferrà C; Berlanga JJ; Banda ED; Ponce C; Salar A; Alonso E; Espanñol I; Riu C; Grañena A Bone Marrow Transplant; 1996 Dec; 18(6):1135-9. PubMed ID: 8971384 [TBL] [Abstract][Full Text] [Related]
8. Prevention of graft versus host disease following allogeneic bone marrow transplantation. Powles RL; Goss GD; Millar J; Maitland J; Borthwick-Clark C; Al-Jundi A Tokai J Exp Clin Med; 1985 Jun; 10(2-3):133-8. PubMed ID: 3914738 [No Abstract] [Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic studies of cyclosporine in bone marrow transplantation. Yee GC Transplant Proc; 1990 Jun; 22(3):1327-30. PubMed ID: 2190394 [No Abstract] [Full Text] [Related]
10. Cyclosporin A: use in preventing graft versus host disease. Klemm P Oncol Nurs Forum; 1985; 12(5):25-32. PubMed ID: 3898028 [No Abstract] [Full Text] [Related]
11. Cyclosporin A (CsA): pharmacokinetics, clinical monitoring and pharmacodynamics in bone marrow transplantation (BMT). Carreras Pons E Prog Clin Biol Res; 1989; 309():325-32. PubMed ID: 2675101 [No Abstract] [Full Text] [Related]
12. [Anatomo-clinical presentation of graft-versus-host disease treated with cyclosporin A]. Al Rustom K; Pierard-Franchimont C; Pierard GE Dermatologica; 1985; 171(2):65-71. PubMed ID: 3899758 [TBL] [Abstract][Full Text] [Related]
13. The correlation of cyclosporine serum and whole blood concentrations with toxicity and efficacy after human marrow transplantation. Britton K; Atkinson K; Downs K; Biggs J Transplant Proc; 1985 Apr; 17(2):1667-70. PubMed ID: 3885501 [No Abstract] [Full Text] [Related]
14. A randomized prospective trial comparing cyclosporine and methotrexate given for prophylaxis of graft-versus-host disease after bone marrow transplantation. Biggs JC; Atkinson K; Gillett E; Downs K; Concannon A; Dodds A Transplant Proc; 1986 Apr; 18(2):253-5. PubMed ID: 3515659 [No Abstract] [Full Text] [Related]
15. Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation. Yanik G; Levine JE; Ratanatharathorn V; Dunn R; Ferrara J; Hutchinson RJ Bone Marrow Transplant; 2000 Jul; 26(2):161-7. PubMed ID: 10918426 [TBL] [Abstract][Full Text] [Related]
16. Cyclosporin a: a new era in organ transplantation. DeBakey ME Compr Ther; 1984 Feb; 10(2):7-15. PubMed ID: 6368108 [No Abstract] [Full Text] [Related]
17. Cold agglutinin disease following allogeneic bone marrow transplantation. Tamura T; Kanamori H; Yamazaki E; Ohtsuka M; Hataoka K; Maeda K; Okamoto R; Tanabe J; Fujita H; Hashimoto Y Bone Marrow Transplant; 1994 Mar; 13(3):321-3. PubMed ID: 8199573 [TBL] [Abstract][Full Text] [Related]
18. [Allogeneic bone marrow transplantation in the treatment of leukemia--a preliminary report]. Chen YC; Wang CH; Lin DT; Lui PT; Cheng AL; Liu TW; Tsay W; Tien HF; Liu MC; Chuu WM Taiwan Yi Xue Hui Za Zhi; 1987 May; 86(5):490-6. PubMed ID: 3305776 [No Abstract] [Full Text] [Related]
19. Does oxypentifylline reduce the intensity of acute graft-versus-host disease following allogeneic bone marrow transplantation? Ghosh K; Hutchinson RM Haematologia (Budap); 1996; 28(1):45-51. PubMed ID: 9283904 [TBL] [Abstract][Full Text] [Related]
20. [Transplantation of allogeneic bone marrow treated in vitro with Campath-1 monoclonal antibody]. Chapuis B; Helg C; Maurice P; Wyss M; Pipard G; Irlé C; Jeannet M Schweiz Med Wochenschr; 1985 Oct; 115(43):1521-2. PubMed ID: 3909387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]